- Home
- NDLS vs ENZ Comparison
NDLS vs ENZ Comparison
Compare NDLS & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDLS
- ENZ
- Stock Information
- Founded
- NDLS 1995
- ENZ 1976
- Country
- NDLS United States
- ENZ United States
- Employees
- NDLS N/A
- ENZ N/A
- Industry
- NDLS Restaurants
- ENZ Medical Specialities
- Sector
- NDLS Consumer Discretionary
- ENZ Health Care
- Exchange
- NDLS Nasdaq
- ENZ Nasdaq
- Market Cap
- NDLS 34.3M
- ENZ 34.2M
- IPO Year
- NDLS 2013
- ENZ N/A
- Fundamental
- Price
- NDLS $1.18
- ENZ $0.34
- Analyst Decision
- NDLS Strong Buy
- ENZ
- Analyst Count
- NDLS 2
- ENZ 0
- Target Price
- NDLS $3.00
- ENZ N/A
- AVG Volume (30 Days)
- NDLS 122.1K
- ENZ 189.4K
- Earning Date
- NDLS 03-06-2025
- ENZ 03-17-2025
- Dividend Yield
- NDLS N/A
- ENZ 31.52%
- EPS Growth
- NDLS N/A
- ENZ N/A
- EPS
- NDLS N/A
- ENZ N/A
- Revenue
- NDLS $493,271,000.00
- ENZ $29,094,000.00
- Revenue This Year
- NDLS $4.73
- ENZ N/A
- Revenue Next Year
- NDLS $1.30
- ENZ N/A
- P/E Ratio
- NDLS N/A
- ENZ N/A
- Revenue Growth
- NDLS N/A
- ENZ N/A
- 52 Week Low
- NDLS $0.55
- ENZ $0.31
- 52 Week High
- NDLS $2.36
- ENZ $1.30
- Technical
- Relative Strength Index (RSI)
- NDLS 48.32
- ENZ 20.20
- Support Level
- NDLS $1.01
- ENZ $0.45
- Resistance Level
- NDLS $1.20
- ENZ $0.50
- Average True Range (ATR)
- NDLS 0.08
- ENZ 0.04
- MACD
- NDLS 0.00
- ENZ -0.01
- Stochastic Oscillator
- NDLS 89.47
- ENZ 5.68
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.